EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort study

Sikai Wu, Minhua Ye, Guochao Zhang, Liang Dai, Zongfei Wang, Yijian Yu, Sulen Sarioglu, Minghui Yang, Jiajing Sun, Changsheng Yi, Zhicheng Du, William C Cho und 6 weitere

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110296 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Sikai Wu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Taizhou Hospital, Zhejiang University School of Medicine, Taizhou, China; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of D…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoplasm Recurrence, Local, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Peking Union Medical College, National Natural Science Foundation of China, Wenzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSES: Tumor deposits (TDs) are considered poor prognostic factors in esophageal squamous cell carcinoma (ESCC). However, the impact of tumor deposits-positivity (TDP) on ESCC prognosis and recurrence remains unclear. This multicenter retrospective cohort study aimed to investigate the influence of TDP on recurrence and the potential benefit of adjuvant therapy in ESCC. METHODS: Data were collected from four large-scale hospitals on ESCC patients who underwent R0 esophagectomy for stage T1-4N0-3M0 from January 2008 to January 2019. The clinicopathological features, prognosis, and risk factors for TDP were evaluated. Subgroup analyses were conducted based on adjuvant chemotherapy status and recurrence patterns. RESULTS: A total of 2244 patients were enrolled in our study. 688 patients were analyzed after propensity score matching. Patients who were categorized as T1-4N0M0 with TDP status had a similar prognosis to T1-4N1M0 (P = 0.95) or T1-4N2M0 (P = 0.42) with tumor deposits-negativity (TDN) status. In the T1-4N0M0 and T1-4N1M0 stage groups, the 5-year RFS rate and 5-year OS in the TDP group differed significantly from the TDN group (P < 0.001). Among T1-4N0M0 with adjuvant chemotherapy patients, TDP patients had significantly worse OS compared to TDN patients (P < 0.001). Furthermore, TDP patients exhibited a higher cumulative incidence for local recurrence (P < 0.001) and distant recurrence rate (P < 0.001). CONCLUSIONS: TDP is a risk factor for recurrence in ESCC and plays a significant role in the discussion of ESCC treatment strategies. TDP patients may benefit from adjuvant chemotherapy, emphasizing the importance of monitoring these patients during follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNeoplasm Recurrence, LocalEsophageal Squamous Cell CarcinomaHumansRetrospective StudiesMaleFemaleMiddle AgedPrognosisEsophagectomyAgedChemotherapy, AdjuvantNeoplasm StagingRisk FactorsSurvival RatePropensity Score

Stichwörter der Autor:innen

Esophageal squamous cell carcinomaRecurrence patternTumor deposits

Autor:innen und Institutionen

  • Taizhou Hospital, Zhejiang University School of Medicine, Taizhou, China; Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Linhai, China; Department…
  • Taizhou Hospital, Zhejiang University School of Medicine, Taizhou, China; Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), The First Department of Thoracic Surgery, Peking University Cancer Hospital and Institute, Peking University School of Oncology, Beiji…
  • Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Department of Pathology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, China.

Förderung

  • Peking Union Medical College
  • National Natural Science Foundation of China
  • Wenzhou Medical University
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Wu, S., Ye, M., Zhang, G., Dai, L., Wang, Z., Yu, Y., Sarioglu, S., Yang, M., Sun, J., Yi, C., Du, Z., Cho, W. C., Witharana, T., Ma, D., Zhu, C., Li, Y., Ma, L., & Shen, J. (2025). Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort study. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110296

Vancouver

Wu S, Ye M, Zhang G, Dai L, Wang Z, Yu Y, et al. Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort study. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110296

BibTeX
@article{Wu2025,
  author = {Wu, Sikai and Ye, Minhua and Zhang, Guochao and Dai, Liang and Wang, Zongfei and Yu, Yijian and Sarioglu, Sulen and Yang, Minghui and Sun, Jiajing and Yi, Changsheng and Du, Zhicheng and Cho, William C and Witharana, Thivanka and Ma, Dehua and Zhu, Chengchu and Li, Yong and Ma, Liang and Shen, Jianfei},
  title = {Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort study},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110296}
}
Kostenlos starten →